APA (7th ed.) Citation

K, D., GD, B., LJ, G., AA, O., JR, L., T, R., . . . S, S. (2021). The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: A case series. Oncotarget, 12(18), 1836. https://doi.org/10.18632/oncotarget.28046

Chicago Style (17th ed.) Citation

K, Drenner, et al. "The Value of Comprehensive Genomic Sequencing to Maximize the Identification of Clinically Actionable Alterations in Advanced Cancer Patients: A Case Series." Oncotarget 12, no. 18 (2021): 1836. https://doi.org/10.18632/oncotarget.28046.

MLA (9th ed.) Citation

K, Drenner, et al. "The Value of Comprehensive Genomic Sequencing to Maximize the Identification of Clinically Actionable Alterations in Advanced Cancer Patients: A Case Series." Oncotarget, vol. 12, no. 18, 2021, p. 1836, https://doi.org/10.18632/oncotarget.28046.